Institute For Neurodegenerative Disorders

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2001-01-01

Employees: 101

Market Cap: -

Website: http://www.indd.org

Clinical Trials

Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease
Parkinsonian Syndrome

Interventions: Drug: [123I]β-CIT

First Posted Date: 2006-04-18

Last Posted Date: 2014-05-09

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 225

Registration Number: NCT00315250

Locations: 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain

Phase 1

Completed

Conditions: Alzheimer Disease

Interventions: Drug: [123I] IMPY & SPECT Imaging

First Posted Date: 2006-02-06

Last Posted Date: 2014-03-07

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 38

Registration Number: NCT00287248

Locations: 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families

Phase 2

Completed

Conditions: Parkinson Disease
Parkinsonian Syndrome

Interventions: Drug: [123I]B-CIT

First Posted Date: 2006-01-09

Last Posted Date: 2014-05-09

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 62

Registration Number: NCT00273351

Locations: 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression

Phase 2

Completed

Conditions: Parkinson Disease

Interventions: Drug: [123I]B-CIT SPECT imaging

First Posted Date: 2005-08-25

Last Posted Date: 2014-08-08

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 142

Registration Number: NCT00134784

Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

Phase 2

Completed

Conditions: Parkinson's Disease
Parkinsonian Syndrome

First Posted Date: 2005-08-22

Last Posted Date: 2019-04-03

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 500

Registration Number: NCT00132626

Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty

Phase 2

Completed

Conditions: Parkinsonian Syndrome

Interventions: Drug: [123I]ß CIT

First Posted Date: 2005-08-12

Last Posted Date: 2014-07-16

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 169

Registration Number: NCT00129675

Locations: 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson Disease
Parkinsonian Syndrome

First Posted Date: 2005-08-11

Last Posted Date: 2009-08-28

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 30

Registration Number: NCT00129181

Locations: 🇩🇪
Dept. of Neurology, University of Leipzig, Leipzig, Germany
🇮🇹
Department of Neurological Sciences-University of Napoli, Naples, Italy
🇩🇪
Dept. of Neurology Marburg, Phillips-Univ., Marburg, Germany

and more 6 locations

A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease

Phase 2

Completed

Conditions: Parkinsonian Syndrome

Interventions: Drug: [123I]ß CIT and SPECT imaging

First Posted Date: 2005-07-08

Last Posted Date: 2014-05-02

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 232

Registration Number: NCT00117819

Locations: 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease

Completed

Conditions: Parkinson's Disease
Parkinsonian Syndrome

Interventions: Device: Automated Neuropsychological Assessment Matrix

First Posted Date: 2005-07-04

Last Posted Date: 2012-02-09

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 620

Registration Number: NCT00117195

Locations: 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients

Completed

Conditions: Parkinson Disease
Parkinsonian Syndrome

First Posted Date: 2004-11-17

Last Posted Date: 2019-04-03

Lead Sponsor: Institute for Neurodegenerative Disorders

Target Recruit Count: 600

Registration Number: NCT00096876

Locations: 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy